Atrial Fibrillation: Rising Prevalence and Global Impact

HEALTH News

Atrial Fibrillation: Rising Prevalence and Global Impact
Atrial FIBRIILATIONHEART HEALTHMEDICAL RESEARCH
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 69 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 48%
  • Publisher: 71%

A new review article highlights the increasing incidence and prevalence of atrial fibrillation (AF), a heart condition causing irregular heartbeat, and its associated risks. Researchers emphasize the need for effective protocols to prevent and manage AF.

Boston University School of Medicine reported on December 17, 2024, that atrial fibrillation (AF), a heart condition causing an irregular heartbeat in the upper chambers of the heart, affects up to one in three people in the U.S. throughout their lives. Significant complications associated with AF include ischemic stroke, heart failure, myocardial infarction, chronic kidney disease, dementia, and mortality.

In a new review article in the Journal of the American Medical Association, researchers from Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center summarized current evidence regarding the epidemiology, pathophysiology, diagnosis, and management of AF. Given the increasing incidence, prevalence, and lifetime risk of AF, it is crucial to promote the most effective protocols to help reduce risk factors and prevent AF onset, recurrence, and complications in patients. Researchers conducted a PubMed search for English-language articles published between January 1990 and August 15, 2024, concerning the epidemiology, pathophysiology, clinical presentation, prognosis, and management of AF. Their results provided insights into the epidemiology, pathophysiology, screening and detection, clinical presentation, and management of atrial fibrillation. In terms of epidemiology, the age-adjusted incidence per 1,000 person years increased from 3.7 to 13.4 in men and from 2.5 to 8.6 in women, while the prevalence increased from 20.4 to 96.2 in men and from 13.7 to 49.4 in women between 1990 and 2024. The highest prevalence was observed in high-income countries in North America, Australasia, and Western Europe. Globally, the prevalence was higher in men (approximately 28 million) than in women (approximately 25 million).

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Atrial FIBRIILATION HEART HEALTH MEDICAL RESEARCH CARDIOLOGY PUBLIC HEALTH

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study: 40% of newly diagnosed heart failure patients also have atrial fibrillationStudy: 40% of newly diagnosed heart failure patients also have atrial fibrillationA new study by researchers at Intermountain Health in Salt Lake City finds that 40 percent of newly diagnosed heart failure patients also have atrial fibrillation – a combination of cardiac disorders that researchers found results in significantly poorer outcomes for patients.
Read more »

Want to stave off a stroke? Study finds simple change can reduce risk by nearly a THIRDWant to stave off a stroke? Study finds simple change can reduce risk by nearly a THIRDResearchers tracked hundreds of thousands of people in their fifties to see what proportion developed atrial fibrillation - an abnormal heartbeat which is a major risk factor for strokes.
Read more »

Examining leptospirosis prevalence and risk factors in ChinaExamining leptospirosis prevalence and risk factors in ChinaAnnouncing a new article publication for Zoonoses journal. Leptospirosis is a re-emerging zoonotic disease that significantly impacts animals and human health worldwide.
Read more »

Obesity prevalence and BMI decrease in the US for the first time in a decadeObesity prevalence and BMI decrease in the US for the first time in a decadeObesity prevalence in the US decreased in 2023, with significant drops in the South, highlighting the impact of GLP-1RA medications on health trends.
Read more »

Anticoagulants fail to reduce cognitive decline in younger adults with AFibAnticoagulants fail to reduce cognitive decline in younger adults with AFibPrescribing anti-clotting medications to adults younger than age 65 who have atrial fibrillation (AFib) but no other risk factors for stroke did not reduce the risk of cognitive decline, stroke or transient ischemic attack (TIA), according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.
Read more »

Depression genes amplify women's heart disease riskDepression genes amplify women's heart disease riskStudy reveals a sex-specific link between genetic risks for psychiatric disorders and cardiovascular diseases (CVDs), with women showing a higher risk of atrial fibrillation, coronary artery disease, and heart failure linked to genetic predisposition to major depression. Menopause and modifiable factors like BMI and smoking amplify these risks.
Read more »



Render Time: 2025-02-19 17:39:06